Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-04-03 @ 3:02 PM
Study NCT ID:
NCT07484269
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-20
First Post:
2026-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2031-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-16
First Submit QC Date:
None
Study First Post Date:
2026-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-16
Last Update Post Date:
2026-03-20
Last Update Post Date Type:
ACTUAL